Akoya Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $21,344 | $18,814 | $23,164 | $18,350 |
Gross Profit | 14,389 | 11,724 | 13,386 | 8,379 |
EBITDA | -5,712 | -6,039 | -8,570 | -18,758 |
EBIT | -7,864 | -10,496 | -20,809 | |
Net Income | -8,199 | -10,533 | -13,149 | -23,484 |
Net Change In Cash | 21,344 | 18,814 | 23,164 | 18,350 |
Free Cash Flow | -4,024 | -9,690 | -11,211 | -21,634 |
Cash | 11,779 | 12,557 | 8,923 | 13,039 |
Basic Shares | 49,560 | 49,503 | 49,419 | 49,188 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $81,672 | $96,633 | $74,859 | $54,917 |
Gross Profit | 47,878 | 56,305 | 43,390 | 34,218 |
EBITDA | -37,136 | -45,632 | -58,815 | -35,168 |
EBIT | -44,790 | -54,522 | -65,964 | -39,960 |
Net Income | -55,365 | -63,323 | -70,641 | -42,935 |
Net Change In Cash | 81,672 | 96,633 | 74,859 | 54,917 |
Cost of Revenue | -38,849 | 95,873 | ||
Free Cash Flow | -46,559 | -54,552 | -60,856 | -41,162 |
Cash | 11,779 | 83,125 | 74,229 | 113,079 |
Basic Shares | 49,418 | 44,434 | 37,746 | 37,424 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.17 |
2024-09-30 | -$0.17 |
2024-06-30 | -$0.27 |
2024-03-31 | -$0.48 |
